Endocrine, Bone and Other Drug Classes: Antidiabetics, Corticosteroids, Bisphosphonates, SERMs and PDE5 Inhibitors
Updated
These classes cover diabetes, inflammation, bone health, hormone receptors and erectile dysfunction. The exam asks about their administration rules, such as how to take a bisphosphonate, as much as their names. Each class below covers its drugs, what gets tested and practice questions.
Two skills carry most of the Medications domain, and each has its own quiz. The first is drug class identification: recognising which class a drug belongs to from its name or its stem, which is what the drug class identification quiz drills across every class. The second is brand and generic recall, because the exam switches between the two names freely and expects you to follow. Pair this guide with the brand and generic quiz until the brand and generic pairs in the tables below come back without effort.
Antidiabetic Drugs
Also called oral antidiabetic medications and injectable non-insulin agents for type 2 diabetes · suffix class-specific suffixes
Quick answer
- Big picture: type 2 diabetes drugs come in subclasses that each work differently. Metformin (a biguanide) is first-line, sulfonylureas push the pancreas to release insulin, DPP-4 inhibitors (-gliptin) and GLP-1 agonists (semaglutide, dulaglutide) act on the incretin system, and SGLT2 inhibitors (-gliflozin) dump glucose into the urine.
- High-yield suffixes: the -gliptin ending signals a DPP-4 inhibitor (sitagliptin is Januvia) and the -gliflozin ending signals an SGLT2 inhibitor (empagliflozin is Jardiance). Most GLP-1 agonists end in -glutide (semaglutide is Ozempic for type 2 diabetes and Wegovy for weight management).
- Safety cues: metformin carries a rare lactic acidosis risk and is held around iodinated contrast imaging in at-risk patients (reduced kidney function, liver disease, alcoholism, heart failure, or intra-arterial contrast), sulfonylureas cause hypoglycemia and weight gain, SGLT2 inhibitors cause urinary and genital yeast infections, and GLP-1 agonists cause nausea and weight loss.
What gets tested
- Matching brand to generic across subclasses (Glucophage is metformin, Januvia is sitagliptin, Jardiance is empagliflozin, Ozempic is semaglutide)
- Reading the -gliptin suffix as DPP-4 inhibitor, the -gliflozin suffix as SGLT2 inhibitor, and the -glutide suffix as GLP-1 agonist
- Knowing metformin is first-line, works in the liver, and is held around iodinated contrast imaging in patients with reduced kidney function or other lactic acidosis risk factors
- Recognizing that sulfonylureas (glipizide, glimepiride, glyburide) stimulate insulin release and can cause hypoglycemia and weight gain
- Identifying the signature side effects of SGLT2 inhibitors (genital and urinary infections) and GLP-1 agonists (nausea, weight loss, often weekly injections)
- Telling Ozempic (type 2 diabetes) apart from Wegovy (chronic weight management), since both are semaglutide but are different products that are never swapped for each other
What is not tested
You do not need to memorize A1C or blood glucose target numbers, the prescriber's dose titration algorithm, or the detailed biochemistry of the incretin pathway. You do still need the practical product facts, because the exam covers strengths and doses, dosage forms, routes of administration, special handling and administration instructions, and duration of therapy: know that metformin is an oral tablet that comes in immediate release and extended release forms, that Ozempic and Trulicity are weekly subcutaneous pens, that Victoza is a daily pen, and that semaglutide also comes as an oral tablet. Insulin is its own separate class (rapid, short, intermediate, and long acting products) and is studied on its own rather than as an oral antidiabetic. What the exam does not ask you to do is choose or adjust a patient's therapy.
Why antidiabetic drugs matter
Diabetes drugs are dispensed constantly, and metformin is one of the most prescribed medications in the United States. GLP-1 agonists such as semaglutide (Ozempic for type 2 diabetes, Wegovy for chronic weight management) and SGLT2 inhibitors are among the fastest-growing prescriptions, so technicians see them daily. Because the class spans several subclasses with distinct suffixes and safety points, it is high-yield for the Medications domain.
Antidiabetic Drugs at a glance
| Generic | Brand | Primary indication |
|---|---|---|
| metformin | Glumetza, Fortamet (Glucophage is discontinued) | type 2 diabetes (biguanide, first-line) |
| glipizide | Glucotrol | type 2 diabetes (sulfonylurea) |
| glimepiride | Amaryl | type 2 diabetes (sulfonylurea) |
| glyburide | DiaBeta (Glynase) | type 2 diabetes (sulfonylurea) |
| sitagliptin | Januvia | type 2 diabetes (DPP-4 inhibitor) |
| linagliptin | Tradjenta | type 2 diabetes (DPP-4 inhibitor) |
| saxagliptin | Onglyza | type 2 diabetes (DPP-4 inhibitor) |
| empagliflozin | Jardiance | type 2 diabetes, heart failure, and chronic kidney disease (SGLT2 inhibitor) |
| dapagliflozin | Farxiga | type 2 diabetes, heart failure, and chronic kidney disease (SGLT2 inhibitor) |
| canagliflozin | Invokana | type 2 diabetes and diabetic kidney disease (SGLT2 inhibitor) |
| semaglutide | Ozempic; Wegovy; Rybelsus (oral tablet) | type 2 diabetes as Ozempic and Rybelsus (GLP-1 agonist); the Wegovy brand of semaglutide is approved for chronic weight management, not for blood glucose control |
| dulaglutide | Trulicity | type 2 diabetes (GLP-1 agonist, weekly injection) |
| liraglutide | Victoza | type 2 diabetes (GLP-1 agonist, daily injection) |
| pioglitazone | Actos | type 2 diabetes (thiazolidinedione) |
| repaglinide | Prandin | type 2 diabetes (meglitinide) |
Mechanism of action
Antidiabetic drugs lower blood glucose through several distinct mechanisms, one per subclass. Metformin, a biguanide, decreases glucose production by the liver, slows intestinal glucose absorption, and improves the body's sensitivity to insulin, which is why it is first-line and does not by itself cause hypoglycemia. Sulfonylureas (glipizide, glimepiride, glyburide) and the short-acting meglitinides (repaglinide) stimulate the pancreas to release more insulin. DPP-4 inhibitors, the gliptins (sitagliptin, linagliptin, saxagliptin), block the enzyme that breaks down incretin hormones, which raises insulin and lowers glucagon after meals. GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) are incretin mimetics, usually given by injection but also available as an oral semaglutide tablet, that boost glucose-dependent insulin release, slow stomach emptying, and reduce appetite, so they often cause weight loss. SGLT2 inhibitors, the gliflozins (empagliflozin, dapagliflozin, canagliflozin), block glucose reabsorption in the kidney so extra glucose leaves in the urine. Pioglitazone, a thiazolidinedione, improves insulin sensitivity in fat and muscle. Insulin itself is a separate injectable class used when these agents are not enough.
Common and important side effects
- Metformin: gastrointestinal upset (nausea, diarrhea, metallic taste), vitamin B12 deficiency with long-term use, and rare but serious lactic acidosis, especially with kidney impairment
- Sulfonylureas and meglitinides: hypoglycemia (low blood sugar) and weight gain because they raise insulin directly
- DPP-4 inhibitors (-gliptin): generally well tolerated, with headache, upper respiratory symptoms, and rare severe joint pain or pancreatitis; saxagliptin (Onglyza) and alogliptin also carry a warning about hospitalization for heart failure
- SGLT2 inhibitors (-gliflozin): genital yeast infections, urinary tract infections, increased urination, dehydration, and rare euglycemic ketoacidosis
- GLP-1 agonists (-glutide): nausea, vomiting, diarrhea, decreased appetite and weight loss, with a boxed warning about thyroid C-cell tumors and a risk of pancreatitis
- Thiazolidinedione (pioglitazone): fluid retention, edema, weight gain, decreased bone density, and a bladder cancer signal, with a boxed warning for congestive heart failure (starting it is contraindicated in NYHA class III or IV heart failure)
Key interactions
- Metformin is stopped at the time of or before iodinated contrast imaging in patients with an eGFR of 30 to 60, a history of liver disease, alcoholism, or heart failure, or who will receive intra-arterial contrast, because reduced kidney function can raise the risk of lactic acidosis. Kidney function is rechecked 48 hours later before metformin is restarted.
- Alcohol increases the lactic acidosis risk with metformin and can worsen hypoglycemia with sulfonylureas
- Combining a sulfonylurea, meglitinide, or insulin with another glucose-lowering drug increases the chance of hypoglycemia
- Beta blockers can mask the warning signs of hypoglycemia (such as a fast heartbeat), which matters most with sulfonylureas and insulin
- Diuretics and other drugs that raise blood sugar can reduce the effect of antidiabetic agents
- Repaglinide (Prandin) must not be taken with gemfibrozil, which raises repaglinide levels about eightfold and can cause severe hypoglycemia
Patient counseling notes
- Know the signs of low blood sugar (shakiness, sweating, dizziness, hunger, fast heartbeat) and keep a fast sugar source handy, especially with sulfonylureas and insulin
- Take metformin with food to reduce stomach upset, and report muscle pain, trouble breathing, or unusual tiredness that could signal lactic acidosis
- With SGLT2 inhibitors, stay hydrated and watch for genital itching or burning with urination, which can signal a yeast or urinary infection
- GLP-1 injections such as Ozempic and Trulicity are often given once weekly under the skin, and nausea usually eases over time as the dose is increased slowly
- Ozempic and Wegovy are both semaglutide, but they are different products with different pens, strengths, and approved uses, so they are never substituted for each other at the counter
- Do not stop a diabetes medication without talking to the prescriber, and keep taking it even when feeling well
Antidiabetic Drugs practice questions
1. A prescription is written for Januvia. Which generic drug should the technician expect to dispense?
- A. Sitagliptin ✓
- B. Empagliflozin
- C. Glipizide
- D. Semaglutide
Answer: A. Januvia is the brand name for sitagliptin, a DPP-4 inhibitor. The -gliptin suffix identifies the DPP-4 class. The distractors are an SGLT2 inhibitor, a sulfonylurea, and a GLP-1 agonist.
2. The suffix -gliflozin, as in empagliflozin, identifies which class of antidiabetic drug?
- A. Sulfonylureas
- B. DPP-4 inhibitors
- C. SGLT2 inhibitors ✓
- D. Biguanides
Answer: C. The -gliflozin ending signals an SGLT2 inhibitor such as empagliflozin (Jardiance) or dapagliflozin (Farxiga). These drugs lower glucose by increasing how much glucose leaves the body in the urine.
3. Metformin is usually held around the time of a procedure using iodinated contrast dye in at-risk patients. Why?
- A. It stains the contrast image
- B. Reduced kidney function can raise the risk of lactic acidosis ✓
- C. It causes severe hypoglycemia during imaging
- D. It reacts with the dye to form crystals
Answer: B. Contrast dye can transiently reduce kidney function, and impaired kidneys plus metformin raise the risk of the rare but serious complication lactic acidosis. The labeling directs holding metformin around imaging for patients with an eGFR of 30 to 60, a history of liver disease, alcoholism, or heart failure, or who receive intra-arterial contrast, with kidney function rechecked 48 hours later before restarting.
4. A patient starting an SGLT2 inhibitor should be counseled to watch for which characteristic side effect?
- A. Persistent dry cough
- B. Genital yeast and urinary tract infections ✓
- C. Muscle pain and dark urine
- D. Ringing in the ears
Answer: B. Because SGLT2 inhibitors push extra glucose into the urine, that sugar-rich environment promotes genital yeast infections and urinary tract infections, which are the signature adverse effects of the class.
5. Which antidiabetic class is given as a subcutaneous injection (often once weekly), commonly causes nausea, and frequently leads to weight loss?
- A. Sulfonylureas
- B. GLP-1 receptor agonists ✓
- C. Biguanides
- D. DPP-4 inhibitors
Answer: B. GLP-1 receptor agonists such as semaglutide (Ozempic) and dulaglutide (Trulicity) are incretin mimetics given under the skin. They slow stomach emptying and reduce appetite, so nausea and weight loss are common. Semaglutide also comes as an oral tablet, but the class is most often injected.
Antidiabetic Drugs cheat sheet
- Metformin (Glucophage): biguanide, first-line, works in the liver, GI upset, low vitamin B12 with long-term use, rare lactic acidosis, hold around contrast dye in at-risk patients
- Sulfonylureas (glipizide, glimepiride, glyburide): stimulate insulin release, cause hypoglycemia and weight gain
- DPP-4 inhibitors, suffix -gliptin (sitagliptin is Januvia): incretin enzyme blockers, well tolerated
- SGLT2 inhibitors, suffix -gliflozin (empagliflozin is Jardiance, dapagliflozin is Farxiga): glucose out in urine, yeast and urinary infections, also used in heart failure and chronic kidney disease
- GLP-1 agonists, mostly -glutide (semaglutide is Ozempic for type 2 diabetes and Wegovy for weight management, dulaglutide is Trulicity): usually injections, oral semaglutide tablets also exist, nausea, weight loss
- Pioglitazone (Actos): thiazolidinedione, edema and weight gain, boxed warning for congestive heart failure, do not start in NYHA class III or IV heart failure
- Note: insulin is a separate injectable class studied on its own
Antidiabetic Drugs: frequently asked questions
What is the first-line drug for type 2 diabetes?
Metformin (Glucophage), a biguanide, is the first-line oral drug for type 2 diabetes. It lowers glucose mainly by reducing how much the liver makes and by improving insulin sensitivity, and on its own it does not cause hypoglycemia.
How do I tell the diabetes drug classes apart by their suffix?
Look at the ending: -gliptin means a DPP-4 inhibitor (sitagliptin), -gliflozin means an SGLT2 inhibitor (empagliflozin, dapagliflozin), and most GLP-1 agonists end in -glutide (semaglutide, dulaglutide, liraglutide). Be careful with the shorter -tide ending on its own: it appears on many peptide drugs outside this class, such as octreotide and teriparatide, and tirzepatide (Mounjaro, Zepbound) acts on both the GLP-1 and GIP receptors rather than GLP-1 alone. Sulfonylureas often start with gli- or gly- (glipizide, glimepiride, glyburide).
What class of drug is metformin (Glucophage)?
Metformin is a biguanide and the usual first-line medicine for type 2 diabetes. It lowers blood glucose mainly by reducing the amount of glucose the liver releases, and on its own it does not cause hypoglycaemia.
What class of drug is Ozempic (semaglutide)?
Semaglutide is a GLP-1 receptor agonist. Sold as Ozempic it is approved for type 2 diabetes; the same drug sold as Wegovy is approved for chronic weight management, not for blood glucose control, so the two brands are not interchangeable.
Related drug classes
Corticosteroids
Also called glucocorticoids, steroids · suffix -sone, -solone, -onide
Quick answer
- Mechanism: corticosteroids enter the cell, bind the glucocorticoid receptor, and change which genes are transcribed. The result is broad suppression of inflammatory mediators and of immune activity.
- The tapering rule: prolonged use suppresses the body's own cortisol production, so therapy is stepped down gradually rather than stopped abruptly. This is the single most tested counseling point in the class.
- Top adverse effects: raised blood glucose, weight gain and fluid retention, insomnia and mood changes, infection risk, and bone loss with long-term use.
What gets tested
- Recognizing the stems: -sone and -solone for systemic agents, -onide for many inhaled and topical products
- Matching brand to generic: Medrol and Solu-Medrol are methylprednisolone, Deltasone is prednisone, Decadron is dexamethasone
- The Medrol Dose Pack and how a tapering schedule reads
- Why steroids are not stopped abruptly after prolonged use
- Counseling to take with food in the morning, and to rinse the mouth after an inhaled steroid
- The blood glucose effect and what it means for patients with diabetes
What is not tested
You are not expected to convert between steroid potencies, decide a taper schedule, or match a steroid to a disease. What matters is stem and brand recognition, the tapering principle, the dose pack format, and the counseling and monitoring points. Strengths, dosage forms, routes, special handling, and duration of therapy are covered by PTCE knowledge area 1.4, which makes the dose pack a very fair target for a question.
Why corticosteroids matter
Prednisone is among the most dispensed medications in the United States, and the Medrol Dose Pack is one of the most recognizable tapering packages a technician will hand across the counter. The class also carries a counseling point with real consequences: stopping a long course abruptly can precipitate an adrenal crisis, which makes it a genuine patient safety issue rather than a memorization exercise.
Corticosteroids at a glance
| Generic | Brand | Primary indication |
|---|---|---|
| prednisone | Rayos (Deltasone is discontinued) | asthma flares, autoimmune conditions, allergic reactions |
| prednisolone | Orapred, Prelone | same uses, often preferred in children as a liquid |
| methylprednisolone | Medrol, Solu-Medrol | dose pack tapers, injections for inflammation |
| dexamethasone | Decadron | potent, long acting: cerebral edema, chemotherapy support, croup |
| hydrocortisone | Cortef, and topical creams | adrenal insufficiency, topical skin inflammation |
| fluticasone | Flovent, Flonase | inhaled for asthma, nasal spray for allergies |
| budesonide | Pulmicort, Rhinocort | inhaled for asthma, nasal for allergies |
| triamcinolone | Kenalog, Nasacort | topical, injectable, and nasal inflammation |
Mechanism of action
Corticosteroids are lipid-soluble, so they pass straight through the cell membrane rather than docking at a receptor on the surface. Inside the cell they bind the glucocorticoid receptor, and the drug and receptor together move into the nucleus and bind DNA at glucocorticoid response elements. From there they act as a transcription switch: they turn up production of anti-inflammatory proteins and turn down production of the inflammatory ones, including the cytokines and enzymes that drive swelling, redness, and immune recruitment. One important downstream effect is suppression of phospholipase A2, which sits upstream of both the prostaglandin and the leukotriene pathways. That is why steroids suppress inflammation more broadly than an NSAID, which blocks only the cyclooxygenase branch. Because the mechanism runs through gene transcription, the effect takes hours to appear rather than minutes, and it persists after the drug has cleared. The same receptor system explains the adverse effects: glucocorticoids also drive glucose production in the liver, break down protein and bone, redistribute fat, and retain sodium and water. Critically, the body senses circulating steroid and shuts down its own production through the hypothalamic-pituitary-adrenal axis. After roughly two weeks of meaningful dosing that shutdown is established, and abruptly removing the drug leaves the patient unable to produce cortisol, which is why the dose must be tapered.
Common and important side effects
- Raised blood glucose, which can destabilize diabetes or unmask it
- Increased appetite, weight gain, and fluid retention
- Insomnia, restlessness, irritability, and mood changes including euphoria or depression
- Increased susceptibility to infection, and masking of the usual signs of infection
- Osteoporosis and higher fracture risk with long-term use
- Stomach irritation and ulcer risk, especially alongside an NSAID
- Thinning skin, easy bruising, and slower wound healing
- Cataracts and raised eye pressure with prolonged use
- Adrenal suppression, and adrenal crisis if the drug is stopped abruptly
- Oral thrush with inhaled steroids if the mouth is not rinsed
Key interactions
- NSAIDs combined with corticosteroids substantially increase the risk of gastrointestinal ulceration and bleeding
- Live vaccines are generally avoided during immunosuppressive doses
- Diabetes medicines may need adjustment, because steroids raise blood glucose
- Strong CYP3A4 inhibitors raise steroid levels, and inducers such as rifampin and phenytoin lower them
- Warfarin response may change in either direction, so INR is monitored
- Combining with a potassium-wasting diuretic can deepen potassium loss
Patient counseling notes
- Take the dose in the morning with food, which matches the body's natural cortisol rhythm and reduces both stomach upset and insomnia
- Follow a tapering schedule exactly as written, and never stop a longer course suddenly
- Rinse the mouth with water and spit after using an inhaled corticosteroid, to prevent oral thrush
- Monitor blood glucose more closely if diabetic, because readings often rise during therapy
- Report signs of infection such as fever or sore throat, since steroids can blunt the usual warning signs
- Carry medical identification when on long-term therapy, so that stress dosing can be considered in an emergency
- Expect a Medrol Dose Pack to step the dose down day by day, and follow the card rather than taking a fixed daily amount
Corticosteroids practice questions
1. A prescription for a Medrol Dose Pack is received. Which generic drug is being dispensed?
- A. Prednisone
- B. Methylprednisolone ✓
- C. Dexamethasone
- D. Hydrocortisone
Answer: B. Medrol is methylprednisolone, and the Medrol Dose Pack is its tapering package. Deltasone is prednisone and Decadron is dexamethasone.
2. Why must long-term corticosteroid therapy be tapered rather than stopped abruptly?
- A. The drug causes rebound inflammation only in the skin
- B. Prolonged use suppresses the body's own cortisol production, so sudden withdrawal can cause adrenal crisis ✓
- C. Abrupt withdrawal causes permanent kidney damage
- D. The tablets must be finished for the pharmacy to bill correctly
Answer: B. Circulating steroid suppresses the hypothalamic-pituitary-adrenal axis, so the adrenal glands stop producing cortisol. Removing the drug suddenly leaves the patient with no cortisol from either source, which can precipitate an adrenal crisis. A taper gives the axis time to restart.
3. What is the standard counseling point after using an inhaled corticosteroid?
- A. Hold the breath for five minutes
- B. Rinse the mouth with water and spit it out ✓
- C. Drink a glass of milk
- D. Lie down for 30 minutes
Answer: B. Steroid left in the mouth suppresses local immunity and allows Candida to overgrow, causing oral thrush. Rinsing with water and spitting after each use is the standard prevention, and it is one of the most frequently asked inhaler counseling points.
4. A patient with type 2 diabetes is starting a course of prednisone. What should they be advised to monitor?
- A. Blood pressure only
- B. Blood glucose, because steroids commonly raise it ✓
- C. Body temperature only
- D. Urine colour
Answer: B. Corticosteroids increase glucose production in the liver and reduce the tissue response to insulin, so blood glucose often rises during therapy. Patients with diabetes are advised to test more frequently, and their diabetes medicines may need temporary adjustment by the prescriber.
5. Which drug stem suggests a systemic corticosteroid?
- A. -olol
- B. -sone or -solone ✓
- C. -pril
- D. -statin
Answer: B. Prednisone, prednisolone, methylprednisolone, dexamethasone, and hydrocortisone all carry the -sone or -solone pattern. The suffix -olol marks beta-blockers, -pril marks ACE inhibitors, and -statin marks the cholesterol drugs.
Corticosteroids cheat sheet
- Stems: -sone and -solone (systemic), -onide (many inhaled and topical)
- Know these pairs: Medrol and Solu-Medrol are methylprednisolone, Deltasone is prednisone, Decadron is dexamethasone, Flonase is fluticasone
- Action: bind the glucocorticoid receptor and alter gene transcription, broadly suppressing inflammation and immunity
- Golden rule: taper, never stop abruptly after prolonged use (risk of adrenal crisis)
- Take in the MORNING with FOOD
- Inhaled steroid: rinse mouth and spit to prevent thrush
- Watch: high blood glucose, weight gain, insomnia, mood change, infection risk, osteoporosis long term
- Broader than an NSAID: steroids suppress both prostaglandin and leukotriene pathways
Corticosteroids: frequently asked questions
Why is prednisone taken in the morning?
The body's own cortisol peaks in the early morning, so morning dosing matches that natural rhythm and causes less disruption to the hypothalamic-pituitary-adrenal axis. It also reduces the insomnia that an evening dose commonly causes. Taking it with food limits stomach upset.
What is a Medrol Dose Pack?
It is a pre-packaged tapering course of methylprednisolone, usually over six days, where the number of tablets falls each day. The card is laid out so the patient can follow the descending schedule directly, which is the point: the dose steps down rather than stopping flat.
What class of drug is prednisone?
Prednisone is a systemic corticosteroid, also called a glucocorticoid. It binds the glucocorticoid receptor and alters gene transcription to suppress inflammation and immune activity. The -sone stem identifies the class.
Why do corticosteroids raise blood sugar?
Glucocorticoids increase glucose production in the liver and make tissues less responsive to insulin, both of which push blood glucose up. Patients with diabetes usually need to monitor more closely during a course, and occasionally their diabetes medicines are adjusted by the prescriber for the duration.
Related drug classes
Bisphosphonates
Also called the -dronate bone drugs · suffix -dronate
Quick answer
- Mechanism: bisphosphonates bind to the mineral surface of bone, are swallowed by the osteoclasts that break bone down, and disable them. Bone resorption slows, so bone density is preserved.
- The administration rules are the exam's favourite part of this class: first thing in the morning, on a completely empty stomach, with a full glass of plain water, and the patient stays upright and takes nothing else for at least 30 minutes.
- Key warnings: esophageal irritation and ulceration if the rules are not followed, plus osteonecrosis of the jaw and atypical femur fracture with long-term use.
What gets tested
- Recognizing the -dronate suffix and matching brand to generic (Fosamax is alendronate, Actonel is risedronate, Boniva is ibandronate, Reclast is zoledronic acid)
- The full administration and counseling protocol, which is the single highest-yield element of this class
- Why the drug must be taken with plain water and not coffee, juice, or mineral water
- The chelation problem with calcium, antacids, and iron, and the timing that follows
- Osteonecrosis of the jaw and the dental care advice that goes with it
- The weekly, monthly, and yearly dosing options and what each product is
What is not tested
You are not expected to interpret a bone density scan, decide treatment duration, or manage a drug holiday. What matters is the suffix, the brand and generic pairs, the administration protocol in full, and the warning signs patients are told to report. Strengths, dosage forms, routes, special handling, and administration instructions are explicitly inside PTCE knowledge area 1.4, and this class is close to a model question for that objective.
Why bisphosphonates matter
Alendronate is widely dispensed for osteoporosis, and no other common oral medicine carries such a specific and consequential set of administration instructions. Getting them wrong causes real harm, from esophageal ulceration to a drug that simply does not absorb. That combination makes bisphosphonates one of the most reliably tested counseling scenarios on the exam.
Bisphosphonates at a glance
| Generic | Brand | Primary indication |
|---|---|---|
| alendronate | Fosamax, Binosto | osteoporosis prevention and treatment; daily or weekly |
| risedronate | Actonel, Atelvia | osteoporosis, Paget disease; daily, weekly, or monthly |
| ibandronate | Boniva | postmenopausal osteoporosis; monthly tablet or quarterly injection |
| zoledronic acid | Reclast, Zometa | osteoporosis (yearly infusion); cancer-related bone complications |
| pamidronate | generic (infusion) | high blood calcium of malignancy, Paget disease |
Mechanism of action
Bone is not static. Osteoclasts constantly dissolve small patches of it and osteoblasts rebuild them, and osteoporosis develops when the dissolving outpaces the rebuilding. Bisphosphonates are chemical analogues of pyrophosphate, a natural component of bone mineral, and they have an extremely high affinity for hydroxyapatite, the calcium crystal that makes bone hard. Given by mouth or by infusion, they travel to the skeleton and bind tightly to exposed mineral surfaces, concentrating exactly where resorption is most active. When an osteoclast then attaches to that surface and begins dissolving it, the drug is released into the acidic pocket beneath the cell and taken up. Inside the osteoclast, the nitrogen-containing bisphosphonates such as alendronate and zoledronic acid inhibit farnesyl pyrophosphate synthase, an enzyme in the pathway that produces the lipid anchors the cell needs to maintain its ruffled border and stay attached to bone. The osteoclast loses its ability to resorb and undergoes programmed cell death. Resorption slows, the rebuilding side catches up, and bone density rises modestly while fracture risk falls. Two practical consequences follow from the chemistry. First, that same affinity for calcium means any calcium in the gut, from food, dairy, supplements, antacids, or even mineral-rich water, will bind the drug before it can be absorbed. Oral absorption is already extremely poor, well under one percent, so anything in the stomach effectively wipes it out. Second, the drug binds to bone for years, which is why effects persist long after the last dose and why long-term use is linked to the rare complications of jaw osteonecrosis and atypical femoral fracture.
Common and important side effects
- Esophageal irritation, inflammation, and ulceration, especially if the patient lies down or takes too little water
- Heartburn, abdominal pain, nausea, and difficulty swallowing
- Musculoskeletal pain in bones, joints, or muscles, occasionally severe
- Osteonecrosis of the jaw, a rare failure of jaw bone to heal, most often following dental extraction or in cancer patients on high-dose intravenous therapy
- Atypical femur fracture, a rare fracture of the thigh bone often preceded by weeks of dull thigh or groin pain
- An acute phase reaction after intravenous dosing: fever, muscle aches, and flu-like symptoms for a day or two
- Low blood calcium, particularly if vitamin D is deficient
- Eye inflammation, which is uncommon
Key interactions
- Calcium supplements, antacids, iron, and magnesium bind the drug and block the little absorption there is, so they are separated by at least 30 minutes and usually longer
- Any food or beverage other than plain water reduces absorption dramatically
- NSAIDs add to the risk of gastrointestinal irritation
- Proton pump inhibitors may reduce the effectiveness of some oral bisphosphonates
- Loop diuretics and other drugs that lower calcium can deepen hypocalcemia
Patient counseling notes
- Take the tablet first thing in the morning after getting up, before any food, drink, or other medicine
- Swallow it whole with a full glass, roughly 6 to 8 ounces, of plain water. Not coffee, tea, juice, milk, or mineral water, because minerals bind the drug
- Stay fully upright, sitting or standing, for at least 30 minutes afterwards. Ibandronate requires 60 minutes. Do not lie down
- Wait at least 30 minutes, and ideally until after the first food of the day, before taking anything else, including calcium and vitamin D
- Do not chew or suck the tablet, because it can ulcerate the mouth and throat
- Tell your dentist you take this medicine, and try to complete major dental work before starting long-term therapy
- Report new or worsening heartburn, painful or difficult swallowing, or chest pain under the breastbone
- Report persistent thigh or groin pain, which can precede an unusual fracture, and any jaw pain or non-healing dental socket
Bisphosphonates practice questions
1. A prescription for Fosamax is received. Which generic drug does the technician dispense?
- A. Risedronate
- B. Alendronate ✓
- C. Ibandronate
- D. Zoledronic acid
Answer: B. Fosamax is alendronate. Actonel is risedronate, Boniva is ibandronate, and Reclast is zoledronic acid. All carry the -dronate suffix that identifies the bisphosphonate class.
2. What is the correct way to take an oral bisphosphonate such as alendronate?
- A. At bedtime with a snack
- B. First thing in the morning with a full glass of plain water, staying upright for at least 30 minutes ✓
- C. With breakfast and a calcium supplement
- D. Any time of day, crushed into applesauce
Answer: B. Absorption is extremely poor and is destroyed by anything other than plain water, so the dose is taken on an empty stomach on waking. Staying upright for at least 30 minutes prevents the tablet lodging in the esophagus, where it can cause ulceration. Calcium is exactly what must be separated from the dose.
3. Why must a bisphosphonate be taken with plain water rather than coffee, juice, or milk?
- A. Other beverages destroy the tablet coating
- B. Minerals such as calcium bind the drug in the gut and prevent absorption ✓
- C. The drug tastes unpleasant in other liquids
- D. Other beverages accelerate absorption to a dangerous degree
Answer: B. Bisphosphonates have a very high affinity for calcium and other divalent cations. Milk, juice, mineral water, and antacids all supply those cations, which bind the drug into a complex that cannot be absorbed. Oral absorption is under one percent at the best of times, so this matters enormously.
4. Which rare but serious adverse effect is associated with long-term bisphosphonate use and dental procedures?
- A. Osteonecrosis of the jaw ✓
- B. Permanent tooth staining
- C. Gingival hyperplasia
- D. Oral thrush
Answer: A. Osteonecrosis of the jaw is a rare failure of jaw bone to heal, most often after a tooth extraction and most common in cancer patients receiving high-dose intravenous bisphosphonates. Patients are advised to tell their dentist and to complete major dental work before starting long-term therapy where possible.
5. A patient taking alendronate reports persistent dull pain in the thigh and groin. Why should this be escalated?
- A. It indicates the drug is working
- B. It can precede an atypical femur fracture ✓
- C. It is a sign of low blood pressure
- D. It indicates an allergic reaction
Answer: B. Atypical femoral fractures are a rare complication of long-term bisphosphonate therapy, and they are frequently preceded by weeks or months of dull aching pain in the thigh or groin. Reporting it early allows imaging before a complete fracture occurs.
Bisphosphonates cheat sheet
- Suffix: -dronate
- Know these pairs: Fosamax is alendronate, Actonel is risedronate, Boniva is ibandronate, Reclast is zoledronic acid
- Action: bind bone mineral, disable osteoclasts, slow bone resorption
- THE PROTOCOL: morning, empty stomach, full glass of PLAIN water, stay UPRIGHT 30 minutes (60 for ibandronate), nothing else by mouth for 30 minutes
- Separate from calcium, antacids, iron, and magnesium
- Oral absorption is under 1 percent, which is why the rules are so strict
- Watch: esophageal ulceration, osteonecrosis of the jaw, atypical femur fracture (thigh or groin pain)
- Dosing options: daily, weekly, monthly tablets; quarterly or yearly injections
Bisphosphonates: frequently asked questions
Why must patients stay upright for 30 minutes after taking alendronate?
If the tablet lingers in the esophagus it can dissolve there and cause inflammation or an ulcer, which is painful and can be serious. Staying sitting or standing lets gravity carry it into the stomach. Ibandronate requires 60 minutes upright rather than 30, so always check the specific product.
What happens if a bisphosphonate is taken with breakfast?
It largely will not be absorbed. Oral bioavailability is already well under one percent, and calcium and other minerals in food bind the drug in the gut, so taking it with a meal can eliminate the dose entirely. The patient gets the risks of the drug and none of the benefit.
What class of drug is alendronate (Fosamax)?
Alendronate is a bisphosphonate, identified by the -dronate suffix. It binds to bone mineral and inhibits osteoclasts, the cells that break bone down, which slows bone loss and reduces fracture risk in osteoporosis.
Why do patients on bisphosphonates need to tell their dentist?
Bisphosphonates suppress the bone turnover that jaw bone needs in order to heal after a procedure such as an extraction, which is why osteonecrosis of the jaw is a recognized rare complication. Telling the dentist allows the risk to be planned around, and where possible major dental work is completed before long-term therapy begins.
Related drug classes
SERMs
Also called selective estrogen receptor modulators · suffix -ifene
Quick answer
- The defining idea: a SERM is not simply an estrogen blocker. It blocks the estrogen receptor in some tissues and activates it in others, which is what selective means.
- The two to know: tamoxifen blocks estrogen in breast tissue but activates it in the uterus, which is why it treats breast cancer but raises endometrial cancer risk. Raloxifene blocks it in both breast and uterus while activating it in bone, so it builds bone without the uterine risk.
- Shared risk: both raise the chance of blood clots, including deep vein thrombosis and pulmonary embolism, and both commonly cause hot flashes and leg cramps.
What gets tested
- Recognizing the -ifene suffix and matching brand to generic (Soltamox is tamoxifen, Evista is raloxifene)
- The tissue-selective concept, which is the whole point of the class
- Why tamoxifen carries a uterine cancer warning and raloxifene does not
- The blood clot risk shared by both agents
- The CYP2D6 interaction: strong inhibitors such as paroxetine and fluoxetine reduce tamoxifen's activation
- Which agent is used mainly for breast cancer and which mainly for osteoporosis
What is not tested
You are not asked to stage breast cancer, select adjuvant therapy, or interpret receptor status beyond the basic idea that these drugs act on the estrogen receptor. Concentrate on the suffix, the brand and generic pairs, the tissue-selective principle, the warnings, and the counseling points. Strengths, dosage forms, routes, special handling, and duration of therapy fall under PTCE knowledge area 1.4 and remain testable.
Why serms matter
SERMs are the cleanest illustration on the whole exam of a drug whose effect depends on the tissue rather than the molecule, which makes them a favourite conceptual question. They also carry serious, specific warnings that a technician needs to recognize, and tamoxifen's CYP2D6 interaction is a genuine, frequently encountered clinical problem because the interacting drugs are common antidepressants.
SERMs at a glance
| Generic | Brand | Primary indication |
|---|---|---|
| tamoxifen | Soltamox | hormone receptor positive breast cancer treatment and risk reduction |
| raloxifene | Evista | postmenopausal osteoporosis, and breast cancer risk reduction |
| ospemifene | Osphena | painful intercourse due to menopausal vaginal changes |
| clomiphene | generic | ovulation induction in infertility |
Mechanism of action
The estrogen receptor does not work alone. When estrogen binds it, the receptor changes shape and then recruits helper proteins called coactivators or corepressors, and it is the balance of those helpers, which differs from tissue to tissue, that decides whether the gene is switched on or off. A selective estrogen receptor modulator exploits this. It binds the receptor and forces a shape that recruits corepressors in some tissues and coactivators in others, so the very same molecule behaves as an antagonist in one organ and an agonist in another. Tamoxifen is the classic example. In breast tissue it acts as an antagonist, blocking the estrogen signal that hormone receptor positive breast cancer cells depend on to grow, which is why it is central to treating and preventing that disease. In the uterus, however, it behaves as a weak agonist, stimulating the endometrium, which is why long-term use raises the risk of endometrial hyperplasia and uterine cancer. It also acts as an agonist in bone, which preserves bone density, and it raises clotting risk through effects on the liver. Raloxifene shifts the profile: it is an antagonist in both breast and uterus while remaining an agonist in bone, which is why it is used for osteoporosis and breast cancer risk reduction without carrying tamoxifen's uterine warning. Tamoxifen adds one further wrinkle: it is a prodrug that must be converted by the liver enzyme CYP2D6 into endoxifen, the metabolite that does most of the work. Strong CYP2D6 inhibitors, which include the antidepressants paroxetine and fluoxetine, can blunt that conversion and reduce the drug's effectiveness, so the pairing is generally avoided.
Common and important side effects
- Hot flashes and night sweats, which are the most common complaint with both agents
- Leg cramps
- Deep vein thrombosis and pulmonary embolism, appearing in boxed warnings for both drugs
- Endometrial hyperplasia and uterine cancer with tamoxifen, which raloxifene does not carry
- Stroke risk, which appears in the boxed warning for raloxifene and for tamoxifen in the risk-reduction setting
- Vaginal discharge, dryness, or bleeding
- Cataracts and other eye changes with long-term tamoxifen
- Nausea and fatigue
Key interactions
- Strong CYP2D6 inhibitors such as paroxetine, fluoxetine, and bupropion reduce the conversion of tamoxifen to its active metabolite and may reduce its effectiveness
- Warfarin's effect is increased by tamoxifen, raising bleeding risk, so INR is monitored closely
- Estrogen products oppose the intended effect and are generally not combined
- Other drugs that raise clot risk add to the thrombotic warning
- Cholestyramine reduces raloxifene absorption
- Aromatase inhibitors are generally not combined with tamoxifen, since they act on the same pathway differently
Patient counseling notes
- Report leg pain, swelling, warmth, or redness, and any sudden shortness of breath or chest pain, because these can signal a blood clot
- Report any abnormal vaginal bleeding promptly if taking tamoxifen, and keep gynecological check-ups
- Expect hot flashes, which are common and often ease over time
- Tell the pharmacist about any antidepressant, because some reduce tamoxifen's effectiveness
- Raloxifene is usually stopped before and during prolonged immobilization such as major surgery or bed rest, because sitting still raises clot risk
- Report sudden vision changes
- Take the medicine consistently: these are long-term therapies where adherence over years is what delivers the benefit
SERMs practice questions
1. What does it mean that tamoxifen is a selective estrogen receptor modulator?
- A. It blocks estrogen receptors everywhere in the body
- B. It activates estrogen receptors everywhere in the body
- C. It blocks estrogen receptors in some tissues and activates them in others ✓
- D. It prevents the body from producing estrogen
Answer: C. Selective means tissue-dependent. Tamoxifen antagonizes the estrogen receptor in breast tissue while acting as an agonist in the uterus and bone. A drug that stopped estrogen production would be an aromatase inhibitor, which is a different class.
2. Why does tamoxifen carry a warning about uterine cancer while raloxifene does not?
- A. Tamoxifen is dosed much higher
- B. Tamoxifen acts as an agonist in the uterus, stimulating the endometrium, whereas raloxifene is an antagonist there ✓
- C. Raloxifene is not absorbed in the pelvis
- D. Tamoxifen is only used in men
Answer: B. The tissue-selective profile differs between the two. Tamoxifen stimulates the endometrium, which over time raises the risk of endometrial hyperplasia and uterine cancer. Raloxifene blocks the receptor in the uterus as well as the breast, so it lacks that risk.
3. A patient taking tamoxifen is prescribed paroxetine. Why should this be flagged?
- A. Paroxetine increases tamoxifen levels to a toxic degree
- B. Paroxetine inhibits CYP2D6 and may reduce tamoxifen's conversion to its active form ✓
- C. The two drugs form a precipitate
- D. Paroxetine causes tamoxifen to be excreted unchanged in bile
Answer: B. Tamoxifen is a prodrug activated by CYP2D6 into endoxifen. Paroxetine is a strong CYP2D6 inhibitor, so combining them can reduce the amount of active metabolite formed and potentially reduce the drug's benefit. An alternative antidepressant is usually chosen.
4. Which serious adverse effect appears in the boxed warnings for both tamoxifen and raloxifene?
- A. Blood clots, including deep vein thrombosis and pulmonary embolism ✓
- B. Permanent hearing loss
- C. Severe neutropenia
- D. Tendon rupture
Answer: A. Both SERMs increase the risk of venous thromboembolism, and both boxed warnings address clot and stroke risk. Patients are counseled to report leg swelling or pain and sudden breathlessness, and raloxifene is typically paused around prolonged immobilization.
5. Which SERM is used primarily for postmenopausal osteoporosis?
- A. Tamoxifen
- B. Raloxifene ✓
- C. Clomiphene
- D. Ospemifene
Answer: B. Raloxifene (Evista) acts as an estrogen agonist in bone, preserving bone density, while blocking the receptor in breast and uterine tissue. Tamoxifen is used mainly in breast cancer, clomiphene induces ovulation, and ospemifene treats menopausal vaginal symptoms.
SERMs cheat sheet
- Suffix: -ifene
- Know these pairs: Soltamox is tamoxifen, Evista is raloxifene
- Concept: SELECTIVE means the same drug blocks the estrogen receptor in some tissues and activates it in others
- Tamoxifen: ANTAGONIST in breast, AGONIST in uterus and bone. Treats breast cancer, raises uterine cancer risk
- Raloxifene: ANTAGONIST in breast and uterus, AGONIST in bone. Treats osteoporosis, no uterine warning
- Both: boxed warnings covering blood clots and stroke; hot flashes and leg cramps are common
- Tamoxifen is a prodrug activated by CYP2D6: avoid strong inhibitors such as paroxetine and fluoxetine
- Report: leg swelling or pain, breathlessness, abnormal vaginal bleeding
SERMs: frequently asked questions
What is the difference between tamoxifen and raloxifene?
Both are SERMs, but their tissue profiles differ. Tamoxifen blocks the estrogen receptor in breast tissue and activates it in the uterus and bone, so it treats breast cancer but raises endometrial cancer risk. Raloxifene blocks the receptor in both breast and uterus while activating it in bone, so it is used for osteoporosis and breast cancer risk reduction without the uterine warning.
What does selective mean in selective estrogen receptor modulator?
It means the drug's effect depends on the tissue rather than being the same everywhere. Binding the receptor changes its shape, and different tissues carry different helper proteins that read that shape as either an on or an off signal. So one molecule can be an estrogen blocker in the breast and an estrogen mimic in bone.
Why can some antidepressants reduce tamoxifen's effectiveness?
Tamoxifen is a prodrug that the liver enzyme CYP2D6 converts into endoxifen, the metabolite responsible for most of its activity. Strong CYP2D6 inhibitors, which include paroxetine and fluoxetine, slow that conversion and can lower endoxifen levels. Prescribers typically select an antidepressant that does not inhibit CYP2D6.
What class of drug is raloxifene (Evista)?
Raloxifene is a selective estrogen receptor modulator, identified by the -ifene suffix. It acts as an estrogen agonist in bone, which preserves bone density in postmenopausal osteoporosis, while blocking the estrogen receptor in breast tissue.
Related drug classes
PDE5 Inhibitors
Also called phosphodiesterase type 5 inhibitors, the -afil drugs · suffix -afil
Quick answer
- Mechanism: PDE5 inhibitors block the enzyme that breaks down cGMP, so cGMP accumulates, smooth muscle relaxes, and blood flow into the tissue increases.
- The absolute contraindication: nitrates. Nitrates raise cGMP and PDE5 inhibitors stop it being cleared, so together they can drop blood pressure catastrophically. This pairing is never dispensed.
- Same drug, two identities: sildenafil is Viagra for erectile dysfunction and Revatio for pulmonary arterial hypertension. Tadalafil is Cialis and Adcirca in the same way, at different strengths and dosing.
What gets tested
- Recognizing the -afil suffix and matching brand to generic (Viagra and Revatio are sildenafil, Cialis and Adcirca are tadalafil, Levitra is vardenafil)
- The nitrate contraindication, which is the single most important fact about this class
- The alpha-blocker interaction and the blood pressure drop it can cause
- Priapism, meaning an erection lasting more than 4 hours, as a medical emergency
- The duration difference: sildenafil lasts hours while tadalafil can last up to 36
- That the same molecule appears under different brands and strengths for a completely different indication
What is not tested
You are not asked to choose between agents, to dose for renal impairment, or to counsel on sexual health beyond the standard safety points. Concentrate on the suffix, the brand and generic pairs including the dual-indication brands, the nitrate contraindication, and the emergency counseling points. Strengths, dosage forms, routes, special handling, and duration of therapy fall under PTCE knowledge area 1.4, and the strength differences between the ED and pulmonary hypertension products make this a realistic order entry trap.
Why pde5 inhibitors matter
Sildenafil and tadalafil are both heavily dispensed, and the nitrate interaction is one of the few genuinely absolute contraindications a technician will meet at the counter. The dual-brand situation is also a practical safety issue: a patient on Revatio three times daily and a patient on Viagra as needed are taking the same molecule on completely different schedules, and confusing them matters.
PDE5 Inhibitors at a glance
| Generic | Brand | Primary indication |
|---|---|---|
| sildenafil | Viagra (ED), Revatio (pulmonary hypertension) | erectile dysfunction; pulmonary arterial hypertension |
| tadalafil | Cialis (ED and BPH), Adcirca (pulmonary hypertension) | erectile dysfunction, BPH, pulmonary arterial hypertension |
| vardenafil | Levitra | erectile dysfunction |
| avanafil | Stendra | erectile dysfunction, with a faster onset |
Mechanism of action
Sexual stimulation causes nerve endings and the vessel lining in the penis to release nitric oxide. Nitric oxide activates an enzyme that produces cyclic guanosine monophosphate, or cGMP, and cGMP is the signal that tells smooth muscle in the arteries and the corpus cavernosum to relax. Relaxed smooth muscle lets blood flow in, and the resulting pressure compresses the veins that would drain it, producing an erection. The enzyme phosphodiesterase type 5 breaks cGMP down and ends the signal. PDE5 inhibitors block that enzyme, so cGMP persists and the relaxation is amplified and prolonged. This is why the class does not work without arousal: the drug does not create the nitric oxide signal, it only stops the response being switched off, so some stimulation is still required to start the process. The same enzyme is abundant in the smooth muscle of the pulmonary arteries, which is why sildenafil and tadalafil are also used to lower pulmonary artery pressure in pulmonary arterial hypertension, marketed there as Revatio and Adcirca at different strengths and schedules. The dangerous interaction follows directly from the mechanism. Nitrates such as nitroglycerin work by donating nitric oxide, driving cGMP production up. Adding a PDE5 inhibitor removes the only route for clearing that cGMP, so the vasodilation compounds and blood pressure can collapse. Sildenafil also has weak activity at PDE6 in the retina, which explains the transient blue-tinted vision some patients report.
Common and important side effects
- Headache, facial flushing, and nasal congestion, all from vasodilation
- Dyspepsia and indigestion
- Back pain and muscle aches, reported more with tadalafil
- Visual changes including a blue tint or light sensitivity, most associated with sildenafil
- Priapism, an erection lasting more than 4 hours, which is a medical emergency because it can cause permanent tissue damage
- Non-arteritic anterior ischemic optic neuropathy, a rare cause of sudden vision loss in one eye
- Sudden hearing loss, sometimes with ringing and dizziness
- Dizziness and low blood pressure, particularly alongside other vasodilators
Key interactions
- Nitrates in any form, including nitroglycerin tablets, sprays, patches, and isosorbide, are an absolute contraindication because of the risk of severe hypotension
- Recreational amyl nitrite (poppers) carries the same absolute contraindication
- Alpha-blockers such as doxazosin and tamsulosin can cause a marked blood pressure drop when combined, so doses are separated and started low
- Strong CYP3A4 inhibitors such as ketoconazole, ritonavir, and clarithromycin raise drug levels, so the dose is reduced
- Grapefruit juice can raise levels through the same pathway
- Other antihypertensives add to the blood pressure lowering effect
Patient counseling notes
- Never take this medicine with any nitrate. If chest pain occurs and you need nitroglycerin, tell the emergency team that you have taken a PDE5 inhibitor and when
- Seek emergency care for an erection lasting more than 4 hours, because delay can cause permanent damage
- Sildenafil is usually taken about 30 to 60 minutes before activity, and a high-fat meal can delay its onset
- Tadalafil can remain active for up to 36 hours, so the timing is much more flexible, and it is also available as a low daily dose
- Stop and seek care for sudden vision loss or sudden hearing loss
- Tell the pharmacist about every other medicine, especially anything for the heart, chest pain, or prostate
- The medicine does not work without sexual stimulation, because it amplifies a natural signal rather than creating one
PDE5 Inhibitors practice questions
1. A patient presents a prescription for sildenafil and their profile lists isosorbide mononitrate. What is the correct action?
- A. Dispense both, advising the patient to space the doses apart
- B. Alert the pharmacist immediately, because nitrates and PDE5 inhibitors are contraindicated together ✓
- C. Reduce the sildenafil strength and dispense
- D. Dispense only the nitrate and cancel the sildenafil
Answer: B. Nitrates plus a PDE5 inhibitor can cause a catastrophic drop in blood pressure, and this is an absolute contraindication rather than a spacing issue. The technician escalates to the pharmacist. Cancelling or altering a prescription is never the technician's decision.
2. Which brand name contains the same active ingredient as Viagra?
- A. Cialis
- B. Revatio ✓
- C. Levitra
- D. Stendra
Answer: B. Both Viagra and Revatio are sildenafil. Viagra is marketed for erectile dysfunction and Revatio for pulmonary arterial hypertension, at different strengths and dosing schedules. Cialis is tadalafil, Levitra is vardenafil, and Stendra is avanafil.
3. PDE5 inhibitors produce their effect by which mechanism?
- A. Increasing testosterone production
- B. Blocking the enzyme that breaks down cGMP, so smooth muscle relaxation is prolonged ✓
- C. Blocking alpha-1 receptors in the prostate
- D. Directly releasing nitric oxide
Answer: B. PDE5 inhibitors block phosphodiesterase type 5, the enzyme that degrades cGMP. With cGMP persisting, smooth muscle relaxation and blood flow are enhanced. They do not release nitric oxide themselves, which is why sexual stimulation is still needed for the drug to work.
4. A patient reports an erection lasting more than 4 hours after taking a PDE5 inhibitor. What should they be told?
- A. This is a normal response, wait for it to resolve
- B. Take a second dose to balance the effect
- C. Seek emergency medical care immediately ✓
- D. Apply a cold compress and rest
Answer: C. This is priapism, a urological emergency. Blood trapped in the tissue becomes deoxygenated and can cause permanent damage to erectile tissue, so the patient needs immediate treatment rather than watchful waiting.
5. Which PDE5 inhibitor has the longest duration of action, up to about 36 hours?
- A. Sildenafil
- B. Vardenafil
- C. Tadalafil ✓
- D. Avanafil
Answer: C. Tadalafil's long half-life gives it a duration of up to roughly 36 hours, which is why it is sometimes called the weekend medicine and why it is also available as a low daily dose. Sildenafil, vardenafil, and avanafil are all considerably shorter acting.
PDE5 Inhibitors cheat sheet
- Suffix: -afil
- Class: PDE5 inhibitors
- Action: block PDE5 so cGMP builds up, smooth muscle relaxes, blood flow increases
- ABSOLUTE contraindication: nitrates of any kind (severe hypotension)
- Dual brands: sildenafil is Viagra (ED) and Revatio (pulmonary hypertension); tadalafil is Cialis and Adcirca
- Tadalafil lasts up to 36 hours; sildenafil is taken 30 to 60 minutes before and is delayed by a fatty meal
- Emergency: erection over 4 hours (priapism), sudden vision loss, sudden hearing loss
- Caution with alpha-blockers: additive blood pressure drop
PDE5 Inhibitors: frequently asked questions
Why can PDE5 inhibitors never be taken with nitrates?
Nitrates donate nitric oxide, which drives up cGMP and dilates blood vessels. PDE5 inhibitors block the enzyme that clears cGMP. Together they remove both the brake and the limit on vasodilation, so blood pressure can fall to a life-threatening level. This is an absolute contraindication, not a matter of separating the doses.
Why is sildenafil sold as both Viagra and Revatio?
It is the same molecule used for two different conditions. Viagra is dosed as needed for erectile dysfunction, while Revatio is dosed at a lower strength on a regular schedule for pulmonary arterial hypertension, where the same vessel-relaxing effect lowers pressure in the lung arteries. Tadalafil follows the same pattern as Cialis and Adcirca.
What class of drug is tadalafil (Cialis)?
Tadalafil is a phosphodiesterase type 5 inhibitor, identified by the -afil suffix. It is used for erectile dysfunction, benign prostatic hyperplasia, and, as Adcirca, pulmonary arterial hypertension. Its distinguishing feature within the class is a duration of action of up to about 36 hours.
Do PDE5 inhibitors work without sexual stimulation?
No. The drug does not create the nitric oxide signal that starts the process; it prevents that signal being switched off early. Arousal is still required to trigger nitric oxide release, which is why patients are counseled that the medicine enables a response rather than producing one on its own.
Related drug classes
More drug class guides
- Cardiovascular Drug Classes
- Antibiotic Drug Classes
- Mental Health and Neurology Drug Classes
- Pain Medication Classes
- Gastrointestinal Drug Classes
- All drug classes compared
Official sources
- StatPearls: Oral Antidiabetic Medications (NBK482386)
- StatPearls: Metformin (NBK518983)
- StatPearls: Sulfonylureas (NBK513225)
- StatPearls: Dipeptidyl Peptidase IV (DPP-4) Inhibitors (NBK542331)
- StatPearls: Sodium-Glucose Transport 2 (SGLT2) Inhibitors (NBK576405)
- StatPearls: Glucagon-Like Peptide-1 Receptor Agonists (NBK551568)
- MedlinePlus: Type 2 diabetes, oral medicines
- MedlinePlus: GLP-1 agonists
- MedlinePlus: Semaglutide Injection (Ozempic, Wegovy)
- FDA label: Glucophage (metformin hydrochloride)
- DailyMed: Ozempic (semaglutide) label
- DailyMed: Actos (pioglitazone) label
- DailyMed: Prandin (repaglinide) label
- ClinCalc DrugStats: Metformin (dispensing rank)
- MedlinePlus: Prednisone
- MedlinePlus: Methylprednisolone
- MedlinePlus: Dexamethasone
- MedlinePlus: Hydrocortisone
- ClinCalc DrugStats: Prednisone (dispensing data)
- MedlinePlus: Alendronate
- MedlinePlus: Risedronate
- MedlinePlus: Ibandronate
- MedlinePlus: Zoledronic Acid Injection
- MedlinePlus: Osteoporosis (topic overview)
- ClinCalc DrugStats: Alendronate (dispensing data)
- MedlinePlus: Tamoxifen
- MedlinePlus: Raloxifene
- MedlinePlus: Sildenafil
- MedlinePlus: Tadalafil
- ClinCalc DrugStats: Sildenafil (dispensing data)
PTCB Quiz Prep is an independent study resource, not affiliated with the Pharmacy Technician Certification Board. This guide is for exam preparation, not medical advice. Part of the PTCB Medications domain.
